Taller, stronger, sharper: Desi pharma is on a rollThe Avendus Capital report attributed the eye-catching growth of large Indian pharma brands to lifestyle diseases, prevalent quality issues...
Expat CEOs a rare commodity in India IncAccording to data sourced from Prime Database, there are 28 non-India expat CEOs among the 2,521 CEOs cumulatively appointed by 2,048 liste...
Desi pharma pangs continue for India despite dose to fortify pharmacy of the world tagIndia, once the 'pharmacy of the world', is struggling to establish itself as an elite player due to poor manufacturing practices that have...
Old economy stocks outperform D-St benchmarks with up to 20% returns in Sept quarterWith balance sheets of corporates being strong, combined with utilisation levels inching towards optimum levels, the capex cycle revival is...
Prathamesh Sinha of 'Shark Tank India' fame demonstrates self-learning gadget to PM Modi, wins his heartPM Modi was in Gandhinagar for the ongoing Digital India Week 2022.
Long & Short of Markets: Why is Jim Rogers saying Namaste, India? How to find a desi TeslaJim Rogers says he’d like to choose an Indian stock over Tesla or Alibaba at this point.
MFs sold 80% of Nifty stocks in Nov, but grabbed remaining 10One of the stocks that saw the biggest selloff by MFs was Bajaj Finserv.
MFs used March rally to realign holdings; so what’s the ‘in’ thing this poll seasonThe quarter witnessed a deterioration in mutual fund flows into equities.
Desi pharma companies see big business in competitive genericsThe opportunity for domestic companies could cumulatively fetch up to a billion dollars in sales.
Desi pharma companies top in biosimilars globallyBiosimilars are approved versions of biopharmaceuticals — complex medicines manufactured using live organisms, as against conventional drug...
Set to conquer US, Indian 'Viagras' may give Pfizer a hard timeThe nearing end of Pfizer's patent will open floodgates of the lucrative US market to Indian companies.
Shut Chinese companies hit desi pharma playersThe shakeup in Chinese factories in the wake of environmental concerns is sending shivers down the spine of the domestic drug industry, wit...
Desi pharma companies need not fear Amazon in USThe official further added that pressure on domestic generics should not increase any further than it already has after increased channel c...
- Trump to hasten desi pharma rejig: Sanjiv Kaul, MD, ChrysCapital
US Congressional hearings on few firms that had astronomically hiked drug prices have scared CEOs who are not considering any amount of pri...
WEF 2015: India Adda makes way for 'Make in India'The 'Make In India' lounge has also painted big hoardings like 'whatever you want to make, make in India' as also 'from satellites to subma...
- Viagra sales go limp after flourish
Viagra and its numerous desi cousins have shown a minuscule growth of 5.43 per cent in sales. Fear of side-effects has hit sales
- Reddy panel holds hope for drug cos
While MNC drug makers have reasons to smile at Satwant Reddy panel’s view that their new formulations be protected from ‘unfair competition...